This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Bio-Rad
other brands :
Biogenesis, Serotec, AbD Serotec, Oxford Biotechnology
product type :
antibody
product name :
UBE2D1 antibody
catalog :
VPA00296KT
quantity :
2 Westerns
price :
108 USD
clonality :
polyclonal
host :
domestic rabbit
conjugate :
nonconjugated
reactivity :
human, mouse
application :
western blot
product information
EntityType :
PrecisionAb™ Polyclonal
EntityCategory :
Antibodies
ProductCode :
VPA00296KT
Description :
UBE2D1 ANTIBODY WITH CONTROL LYSATE
Specificity :
UBE2D1
TargetSpecies :
Human
Host :
Rabbit
Format :
Purified
Isotypes :
Polyclonal IgG
Applications :
WB
ApplicationTypes :
Western Blotting
CrossReactivities :
Mouse
Quantity :
2 Westerns
QuantityValue :
2
QuantityType :
Westerns
GOAccessions :
GO:0000209, GO:0005515, GO:0005829, GO:0004842, GO:0005524, GO:0005654, GO:0007094, GO:0007179, GO:0030509, GO:0031145, GO:0043687, GO:0051436, GO:0051437, GO:0070936
GOTerms :
activation of ubiquitin ligase activity during mitotic cell cycle, alpha-2 macroglobulin receptor-associated protein activity, anaphase promoting complex inhibition during mitotic cell cycle, anaphase-promoting complex activity, anaphase-promoting complex inhibition during mitotic cell cycle, anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein breakdown, anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolism, anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein degradation, APC inhibition during mitotic cell cycle, APC-dependent proteasomal ubiquitin-dependent protein catabolic process, APC-dependent proteasomal ubiquitin-dependent protein catabolism, BMP receptor signaling pathway, BMP signalling pathway, bone morphogenetic protein signaling pathway, bone morphogenetic protein signalling pathway, down regulation of ubiquitin ligase activity during mitotic cell cycle, downregulation of ubiquitin ligase activity during mitotic cell cycle, down-regulation of ubiquitin ligase activity during mitotic cell cycle, E2, E3, GO:0004840, GO:0004841, GO:0045308, inhibition of ubiquitin ligase activity during mitotic cell cycle, Mad2-dependent checkpoint, mitotic anaphase promoting complex inhibition, mitotic anaphase promoting complex inhibitor, mitotic anaphase-promoting complex inhibition, mitotic anaphase-promoting complex inhibitor, mitotic APC inhibition, mitotic APC inhibitor, mitotic SCF complex activator, mitotic SCF complex inhibitor, mitotic ubiquitin ligase activator, mitotic ubiquitin ligase inhibitor, negative regulation of mitotic metaphase/anaphase transition by spindle assembly checkpoint, negative regulation of ubiquitin ligase activity during mitotic cell cycle, negative regulation of ubiquitin-protein ligase activity during mitotic cell cycle, polyubiquitin, positive regulation of ubiquitin ligase activity during mitotic cell cycle, positive regulation of ubiquitin-protein ligase activity during mitotic cell cycle, posttranslational amino acid modification, post-translational amino acid modification, posttranslational modification, post-translational modification, posttranslational protein modification, protein amino acid binding, protein degradation tagging activity, protein folding chaperone, protein polyubiquitinylation, protein polyubiquitylation, protein tagging activity, PTM, stimulation of ubiquitin ligase activity during mitotic cell cycle, TGFbeta receptor signaling pathway, TGF-beta receptor signaling pathway, TGFbeta receptor signalling pathway, TGF-beta receptor signalling pathway, transforming growth factor beta receptor signalling pathway, ubiquitin activity, ubiquitin conjugating enzyme activity, ubiquitin ligase activity, ubiquitin protein ligase activity, ubiquitin protein-ligase activity, ubiquitin:protein-lysine N-ligase (AMP-forming) activity, ubiquitin-conjugating enzyme activity, ubiquitin-ligase activity, up regulation of ubiquitin ligase activity during mitotic cell cycle, upregulation of ubiquitin ligase activity during mitotic cell cycle, up-regulation of ubiquitin ligase activity during mitotic cell cycle
UniprotAccessions :
P51668
Gene :
UBE2D1
GeneID URL :
www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=7321
EntityFormats :
Purified
UNSPSC :
12352203
ProductForm :
Ig fraction - liquid
PriceDKK :
804
PrimarySecondary :
Primary
PriceGBP :
83
PriceEUR :
108
PriceUSD :
108 USD
PriceCHF :
126
PriceSEK :
1077
PriceNOK :
1070
company information
Bio-Rad
Endeavour House, Langford Business Park
Langford Lane, Kidlington
OXON, OX5 1GE
antibody_sales_uk@bio-rad.com
https://www.bio-rad-antibodies.com
1 800 265 7376 (North America)
44 (0)1865 852 700 (Rest of World)
headquarters: UK
Bio-Rad is one of the world's leading antibody manufacturers, offering over 12,000 antibodies and related reagents for a focused range of research areas such as immunology, cancer, veterinary research and cell biology through its antibody experts formerly known as AbD Serotec.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.